Your browser doesn't support javascript.
loading
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control.
Caimmi, D; Baiz, N; Tanno, L K; Demoly, P; Arnavielhe, S; Murray, R; Bedbrook, A; Bergmann, K C; De Vries, G; Fokkens, W J; Fonseca, J; Haahtela, T; Keil, T; Kuna, P; Mullol, J; Papadopoulos, N; Passalacqua, G; Samolinski, B; Tomazic, P V; Valiulis, A; van Eerd, M; Wickman, M; Annesi-Maesano, I; Bousquet, J.
Afiliação
  • Caimmi D; Allergy Unit, Département de Pneumologie et Addictologie, Hôpital Arnaud de Villeneuve, CHRU de Montpellier, Montpellier, France.
  • Baiz N; Sorbonnes Universités, UPMC, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France.
  • Tanno LK; Sorbonnes Universités, UPMC, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France.
  • Demoly P; Allergy Unit, Département de Pneumologie et Addictologie, Hôpital Arnaud de Villeneuve, CHRU de Montpellier, Montpellier, France.
  • Arnavielhe S; Allergy Unit, Département de Pneumologie et Addictologie, Hôpital Arnaud de Villeneuve, CHRU de Montpellier, Montpellier, France.
  • Murray R; Sorbonnes Universités, UPMC, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France.
  • Bedbrook A; Kyomed, Montpellier, France.
  • Bergmann KC; Medical Communications Consultant, MedScript Ltd, Dundalk, Co Louth, Ireland.
  • De Vries G; MACVIA-France, Contre les Maladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
  • Fokkens WJ; Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Fonseca J; Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
  • Haahtela T; Peercode DV, Amsterdam, The Netherlands.
  • Keil T; Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Kuna P; Center for Health Technology and Services Research, CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
  • Mullol J; Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
  • Papadopoulos N; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Passalacqua G; Institute of Social Medicine, Epidemiology and Health Economics, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Samolinski B; Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
  • Tomazic PV; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
  • Valiulis A; Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • van Eerd M; Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
  • Wickman M; Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
  • Annesi-Maesano I; Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, Genoa, Italy.
  • Bousquet J; Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
Clin Exp Allergy ; 47(12): 1526-1533, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28886234
BACKGROUND: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. OBJECTIVE: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. METHODS: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. RESULTS: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. CONCLUSIONS AND CLINICAL RELEVANCE: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Software / Escala Visual Analógica / Rinite Alérgica / Smartphone Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Software / Escala Visual Analógica / Rinite Alérgica / Smartphone Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article